Original Research

Open Clinical Trials for Native Americans With Diabetes Mellitus


 

Look AHEAD: Action for Health in Diabetes

The Look AHEAD study is a multi-center, randomized clinical trial to examine the long-term effects of a lifestyle intervention designed to achieve and maintain weight loss. The study will investigate the effects of the intervention on heart attacks, stroke and cardiovascular-related death in individuals with type 2 diabetes who are also overweight or obese.

ID: NCT00017953
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Location: Southwestern American Indian Center, Phoenix, AZ


Vitamin D and Type 2 Diabetes Study

The goal of the Vitamin D and type 2 diabetes (D2d) study is to determine if vitamin D supplementation works to delay the onset of type 2 diabetes in people at risk for the disease and to gain a better understand how vitamin D affects glucose (sugar) metabolism.

ID: NCT01942694
Sponsor: Tufts Medical Center
Locations: Southwest American Indian Center; Phoenix, AZ; Orlando VA Medical Center, FL; Atlanta VA Medical Center, Decatur, GA; Omaha VA Medical Center, NE


Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point (TTP)

This study will evaluate a behavioral intervention designed to reduce risk factors for type 2 diabetes in American Indian youth aged 7-10 years.

ID: NCT03573856
Sponsor: University of Colorado, Denver
Contact: Katherine Sauder, PhD, katherine.sauder@ucdenver.edu; Dana Dabelea, MD, PhD, dana.dabelea@ucdenver.edu
Location: Childrens Hospital Colorado, Aurora


Strong Men, Strong Communities Diabetes Risk Reduction in American Indian Men (SMSC)

SMSC will inform the design and implementation of culturally informed, community-based lifestyle interventions for diabetes prevention in AI men in our partner communities and elsewhere, as well as in men of other minority groups who experience a heavy burden of diabetes.

ID: NCT02953977
Sponsor: Washington State University
Contact: Kaimi Sinclair, PhD, MPH, kaimi.sinclair@wsu.edu Location: IREACH, Seattle, WA

Pages

Recommended Reading

Open Clinical Trials for Diabetes Mellitus Harm Reduction (FULL)
Federal Practitioner
CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine
Federal Practitioner
Smoking, inactivity most powerful post-MI lifestyle risk factors
Federal Practitioner
Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care
Federal Practitioner
Certain diabetes drugs may thwart dementia
Federal Practitioner
Dapagliflozin approved for reducing HF hospitalization in diabetes
Federal Practitioner
Severe hypoglycemia, poor glycemic control fuels fracture risk in older diabetic patients
Federal Practitioner
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
Federal Practitioner
A Health Care Provider Intervention to Address Obesity in Patients with Diabetes (FULL)
Federal Practitioner
Evaluating a Program Process Change to Improve Completion of Foot Exams and Amputation Risk Assessments for Veterans with Diabetes (FULL)
Federal Practitioner

Related Articles

  • Pharmacology

    Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care

    The United States Public Health Service National Clinical Pharmacy Specialist Committee issues a report on the impact of pharmacy-managed clinics...